Company page

Arch Biopartners, Inc.

Arch Biopartners, Inc. is a public company listed on the Canadian market under the ticker ARCH. With a market capitalization of approximately CAD 30.3 million, Arch Biopartners focuses on developing innovative biopharmaceutical solutions. The company is dedicated to advancing its research and product pipeline to address unmet medical needs.